{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1382262943330765952.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"K Gharehbaghi"}],"foaf:familyName":[{"@value":"Gharehbaghi"}],"foaf:givenName":[{"@value":"K"}]}],"career":[{"institution":{"notation":[{"@value":"Institute of Medical Chemistry, University of Vienna Medical School, Ca 51770."}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1362262943330765952","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1182/blood.v84.12.4316.bloodjournal84124316"},{"@type":"URI","@value":"http://ashpublications.org/blood/article-pdf/84/12/4316/613705/4316.pdf"}],"notation":[{"@value":"Synergistic growth inhibitory and differentiating effects of trimidox and tiazofurin in human promyelocytic leukemia HL-60 cells"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1182/blood.v84.12.4316.bloodjournal84124316_5Eq9e7dBOihZHQvI0IqiQKgbXwl"}]}